BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 239431)

  • 1. Inhibition of adenosine 3',5'-monophosphate phosphodiesterase by nicotinamide and its homologues in vitro.
    Shimoyama M; Kawai M; Nasu S; Shioji K; Hoshi Y
    Physiol Chem Phys; 1975; 7(2):125-32. PubMed ID: 239431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the effect of nicotinamide and ethylnicotinic acid on cyclic AMP phosphodiesterase from rat liver.
    Hoshi Y
    Bull Osaka Med Sch; 1975 Oct; 21(2):77-91. PubMed ID: 181108
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by nicotinic acid [proceedings].
    Saeed SA; Butt NM; Lovely JR; Collier HO
    Biochem Soc Trans; 1979 Oct; 7(5):1042-4. PubMed ID: 229022
    [No Abstract]   [Full Text] [Related]  

  • 4. Possible participation of glucocorticoid in elevation of 3',5'-cyclic AMP levels through inhibition of cyclic AMP phosphodiesterase.
    Tanigawa Y; Kitamura A; Kawamura M; Shimoyama M; Fujii K; Kohri Y; Ueda I
    Physiol Chem Phys; 1978; 10(5):443-8. PubMed ID: 220644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of motility in immature bovine spermatozoa by cyclic AMP phosphodiesterase inhibitors and seminal plasma.
    Hoskins DD; Hall ML; Munsterman D
    Biol Reprod; 1975 Sep; 13(2):168-76. PubMed ID: 177102
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of cyclic AMP phosphodiesterase inhibitors on cardiac sarcolemmal 5'-nucleotidase.
    Heyliger CE; Panagia V; Dhalla NS
    J Pharmacol Exp Ther; 1981 May; 217(2):489-93. PubMed ID: 6262487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of papaverine analogues on 3', 5'-adenosine monophosphate phosphodiesterase activity in rat brain.
    Stancheva S; Uzunov P; Stoytchev T
    Acta Physiol Pharmacol Bulg; 1980; 6(1):41-7. PubMed ID: 6250318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glucagon, phosphodiesterase inhibitors, and trypsin treatment on cyclic 3',5' adenosine monophosphate levels in isolated hepatocytes.
    Moxley MA; Allen DO
    Horm Metab Res; 1975 Jul; 7(4):330-4. PubMed ID: 168140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of adenosine-3', 5'-cyclic monophosphate in the liver of rats treated with nicotinamide.
    Lusini P; Ricci C
    Ital J Biochem; 1983; 32(3):152-60. PubMed ID: 6317608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of 3',5'-cyclic-AMP phosphodiesterase from Paragonimus africanus metacercariae.
    Walter RD
    Tropenmed Parasitol; 1976 Sep; 27(3):337-42. PubMed ID: 10655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of rat heart and brain cyclic 3',5'-adenosine monophosphate phosphodiesterase under the influence of neurohormone "C"].
    Galoian AA; Gurvits BIa; Pogosian MA
    Vopr Biokhim Mozga; 1976; 11():89-96. PubMed ID: 203105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue selective inhibition of cyclic nucleotide phosphodiesterase by denbufylline.
    Wilke R; Arch JR; Nicholson CD
    Arzneimittelforschung; 1989 Jun; 39(6):665-7. PubMed ID: 2476135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physostigmine inhibition of 3',5'-cyclic AMP phosphodiesterase from cat sciatic nerve.
    Curley WH; Standaert FG; Dretchen KL
    J Pharmacol Exp Ther; 1984 Mar; 228(3):656-61. PubMed ID: 6323676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 2-nicotinamidethyl nitrate (SG-75), a new antianginal drug, on the cyclic AMP phosphodiesterase activity.
    Endoh M; Yanagisawa T; Taira N
    Tohoku J Exp Med; 1980 Feb; 130(2):199-201. PubMed ID: 6247783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cyclic nucleotide phosphodiesterase activity by an endogenous factor.
    Ho RJ; Russell TR; Asakawa T; Hucks MW
    J Cyclic Nucleotide Res; 1975; 1(2):81-8. PubMed ID: 177458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reticulol, an inhibitor of cyclic adenosine 3', 5'-monophosphate phosphodiesterase.
    Furutani Y; Shimada M; Hamada M; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1975 Jul; 28(7):558-60. PubMed ID: 168174
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of 2-(4-benzyl-piperidino)-1-(4-hydroxyphenyl)-1-propranolol on adenylate cyclase and 3,5'-cyclic AMP phosphodiesterase in vitro.
    Yamashita Y; Kawai M; Hotta K
    Jpn J Pharmacol; 1976 Jun; 26(3):391-4. PubMed ID: 185445
    [No Abstract]   [Full Text] [Related]  

  • 19. [Modulation of reactivity of cyclic adenosine monophosphate phosphodiesterase under the effect of pyridinecarboxylic acid derivatives and Pt(IV) metal complexes on their basis].
    Tat'ianenko LV; Bogdanov GN; Dobrokhotova OV; Fadeev MA; Fedorov BS
    Biomed Khim; 2006; 52(2):174-9. PubMed ID: 16805389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of rat heart and brain cyclic adenosine-3',5'-monophosphate phosphodiesterase in vitro under the influence of neurohormone C].
    Galoian AA; Gurvits BIa; Pogosian MA
    Biull Eksp Biol Med; 1977 Jun; 83(6):691-3. PubMed ID: 195650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.